DiaMedica Therapeutics
DMAC · NASDAQ
$8.67+$0.80 (+10.17%)TodayMarket closed ·
Prev close $7.87
Who owns DMAC
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 58.1% of DMAC’s shares.
- Trill AB,LLC.16.4%
- EQT Partners AB15.6%
- Jacinto (Richard II)9.2%
- Omega Advisors, Inc.6.4%
- Next 6 largest institutions10.5%
- All other shareholders41.9%
| Holder | Shares | % of shares |
|---|---|---|
| Trill AB,LLC. | 8.83M | 16.38% |
| EQT Partners AB | 8.38M | 15.56% |
| Jacinto (Richard II) | 4.96M | 9.20% |
| Omega Advisors, Inc. | 3.45M | 6.40% |
| BlackRock Institutional Trust Company, N.A. | 1.98M | 3.67% |
| Geode Capital Management, L.L.C. | 894.12K | 1.66% |
| Paragon JV Partners, LLC | 875.00K | 1.62% |
| Millennium Management LLC | 845.31K | 1.57% |
| State Street Investment Management (US) | 646.74K | 1.20% |
| Giuffre (Randall Michael M.D.) | 440.60K | 0.82% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| iShares Russell 2000 ETF | 929.26K | 1.72% |
| Fidelity Small Cap Index Fund | 398.55K | 0.74% |
| Vanguard Extended Market Index Fund | 360.56K | 0.67% |
| iShares Russell 2000 Growth ETF | 346.78K | 0.64% |
| Vanguard Russell 2000 Index Fund | 205.67K | 0.38% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of DMAC in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Pauls Dietrich John | Award | 60.20K | — |
| Semba Charles Pauling | Award | 40.41K | — |
| Pauls Dietrich John | Award | 380.00K | — |
| Parsons James T. | Award | 51.19K | — |
| Giuffre Randall Michael | Award | 40.41K | — |
| Krop Julie | Award | 67.50K | — |
| Kellen Scott | Award | 162.00K | — |
| Lewis Tanya | Award | 40.41K | — |
| O'Connor Daniel J. | Award | 40.41K | — |
| Kuntz Richard | Award | 40.41K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 5.58M
- Days to cover
- 23.29
- % of shares outstanding
- 10.36%
- Average daily volume
- 239.65K
- Change since last report
- +1.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.